. 2020 Apr 29;20:162. doi: 10.1186/s12883-020-01740-1

Table 3.

Treatment Response

Patient	Treatment method (epidural patch with fibrin sealant, paramedian approach) ^a	Treatment response
Patient		Pre-treatment^b	Post-treatment^b (3 months post-patch)
1a)	Bilateral L4/L5, right L5/S1	Upright: 3	Upright: 0
1a)	Bilateral L4/L5, right L5/S1	Supine: 2	Supine: 0
2	Bilateral L4/L5	Upright: 8	Upright: 4
2	Bilateral L4/L5	Supine: 2	Supine: 1
3	Bilateral L4/L5, left L5/S1	Upright: 8	Upright: 2
3	Bilateral L4/L5, left L5/S1	Supine: 0	Supine: 0
4b)	Bilateral L3/4	Upright: 8	Upright: 4
4b)	Bilateral L3/4	Supine: 4	Supine: 2
5	Right L4/L5, right L5/L6	Upright: 7	Upright: 3
5	Right L4/L5, right L5/L6	Supine: 0	Supine: 0
6	Bilateral L5/S1	Upright: 4	Upright: 1
6	Bilateral L5/S1	Supine: 3	Supine: 0

^a3 ml of fibrin sealant to each site

^bPain intensity scale: 0–10, 10 being the most severe

a) At 6 months – suspected rebound intracranial hypertension managed with acetazolamide 250 mg twice daily

b) At 6 months – suspected rebound intracranial hypertension managed with amiloride 10 mg and furosemide 60 mg daily